Indian Hospitals Test Novel Device for Acute Ischemic Stroke Treatment
Key Insights
Sixteen Indian hospitals, led by AIIMS Delhi (search), are testing a new device designed for treating acute ischemic stroke (search) in Indian patients.
The device, developed specifically for Indian patients, aims to address one of the leading causes of mortality and morbidity in the region.
The GRASSROOT Trial is evaluating the Gravity Stent-Retriever System for Reperfusion of Large Vessel Occlusion Stroke (search).
A multi-center trial is underway across sixteen Indian hospitals, spearheaded by AIIMS Delhi (search), to evaluate a novel medical device for the treatment of acute ischemic stroke (search). This device is specifically tailored to address the unique needs of Indian patients, who face a high burden of stroke (search)-related mortality and morbidity.
The device, known as the Gravity Stent-Retriever System for Reperfusion of Large Vessel Occlusion Stroke (search), is being assessed in the GRASSROOT Trial. Acute ischemic stroke (search), a condition characterized by the sudden loss of blood flow to the brain, is a major public health concern in India. The trial aims to determine the device's efficacy in improving outcomes for these patients.
Currently, treatment options for acute ischemic stroke (search) are limited, and this new device represents a potentially significant advancement in the field. The results of the GRASSROOT Trial are eagerly awaited, as they could pave the way for a more effective and accessible treatment option for stroke (search) patients in India.